Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Salmeterol (as xinafoate) 50mcg/inh; dry pwd for inhalation; device with drug in blisters. Serevent Diskus is supplied as a disposable teal green plastic inhaler containing a foil blister strip ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose inhaler, according to a research letter published in JAMA Network ...